Add-on, open-label, phase III study of CS-866AZ
Phase 3
- Conditions
- Essential hypertension
- Registration Number
- JPRN-jRCT2080220290
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patient with essential hypertension not adequately controlled by CS-866 and CS-905 monotherapy, aged 20 years or older
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method